Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP

Neuropsychopharmacol Rep. 2019 Sep;39(3):247-251. doi: 10.1002/npr2.12060. Epub 2019 May 27.

Abstract

Aims: Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder. Although diet may influence the development of PD, the precise mechanisms underlying relationship between diet and PD pathology are unknown. Here, we examined whether dietary intake of glucoraphanin (GF), the precursor of a natural antioxidant sulforaphane in cruciferous vegetables, can affect the reduction of dopamine transporter (DAT) in the mouse striatum after repeated administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).

Methods: Normal food pellet or 0.1% GF food pellet was given into male mice for 28 days from 8-week-old. Subsequently, saline (5 mL/kg × 3, 2-hour interval) or MPTP (10 mg/kg × 3, 2-hour interval) was injected into mice. Immunohistochemistry of DAT in the striatum was performed 7 days after MPTP injection.

Results: Repeated injections of MPTP significantly decreased the density of DAT-immunoreactivity in the mouse striatum. In contrast, dietary intake of 0.1% GF food pellet significantly protected against MPTP-induced reduction of DAT-immunoreactivity in the striatum.

Conclusion: This study suggests that dietary intake of GF food pellet could prevent MPTP-induced dopaminergic neurotoxicity in the striatum of adult mice. Therefore, dietary intake of GF-rich cruciferous vegetables may have beneficial effects on prevention for development of PD.

Keywords: Parkinson disease; dopamine transporter; glucoraphanin; nutrition; sulforaphane.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dietary Supplements
  • Dopamine Plasma Membrane Transport Proteins / genetics
  • Dopamine Plasma Membrane Transport Proteins / metabolism*
  • Glucosinolates / administration & dosage
  • Glucosinolates / pharmacology
  • Glucosinolates / therapeutic use*
  • Imidoesters / administration & dosage
  • Imidoesters / pharmacology
  • Imidoesters / therapeutic use*
  • MPTP Poisoning / drug therapy*
  • MPTP Poisoning / prevention & control
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Oximes
  • Sulfoxides

Substances

  • Antioxidants
  • Dopamine Plasma Membrane Transport Proteins
  • Glucosinolates
  • Imidoesters
  • Oximes
  • Sulfoxides
  • glucoraphanin